Hitting a 52-week high. Looks like Allegra had a killer booth at...

Hitting a 52-week high. Looks like Allegra had a killer booth at the AOA ASM18 Conference with some notable (but not significant) volumes traded in the past week.

From the AMTs website:
"Allegra Orthopaedics will be exhibiting at the AOA ASM18 in Perth.
We will be showcasing the latest technology with an innovative immersive training platform! The technology mixes virtual reality with haptic technologies, for hands-on surgical training and education of orthopaedic surgeons."

Someone must be very interested in the sales potential of VR. However, $0.21 seems significantly overvalued unless they were able to secure some strong sales contracts. Though thats very unlikely given there is yet to be an announcement. And speaking of announcements, there's definitely a lack in news flow to warrant any fundamental changes in value. Volatility seems to be really driven by the illiquidity and shallow LOB.

Their other R&D efforts (Kangaroo tendon + Sr-Ht-Gahnite) will only see them becoming fruitful in the medium term, so seems like a good time to exit now before confirming the news. FYI: I've exited.

AIMHO, DYOR~!